, Tracking Stock Market Picks
Enter Symbol:
Ligand Pharmaceuticals Incorporated (LGND) [hlAlert]

up 76.82 %

Ligand Pharmaceuticals Incorporated (LGND) rated Buy with price target $140 by ROTH Capital

Posted on: Wednesday,  Sep 30, 2015  8:25 AM ET by Roth Capital

Roth Capital rated Buy Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) on 09/30/2015. Previously Roth Capital rated Buy Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) on
11/19/2014., when the stock price was $53.30. Since then, Ligand Pharmaceuticals Incorporated has gained 76.83% as of 09/30/2015's recent price of $94.25.
If you would have followed the previous Roth Capital's recommendation on LGND, you would have gained 76.82% of your investment in 315 days.

Ligand Pharmaceuticals Incorporated discovers, develops and markets new drugs that address critical unmet medical needs of patients in the areas of cancer, pain, skin diseases, men's and women's hormone-related diseases, osteoporosis, metabolic disorders, and cardiovascular and inflammatory diseases. Ligand's proprietary drug discovery and development programs are based on its leadership position in gene transcription technology, primarily related to intracellular receptors.

ROTH researches emerging growth equities in the media, technology, telecommunications, healthcare, consumer, energy and industrial sectors. The research is focused on companies with market capitalization of between $100 million - $1 billion. Our coverage universe includes approximately 180 small cap growth companies around the globe including several companies from China. With an average market cap of approximately $500 million, our objective is to identify rapidly growing companies with significant long term growth prospects.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/30/2015 8:25 AM Buy
86.03 140.00
as of 8/27/2015
1 Week up  0.12 %
1 Month down  -5.28 %
3 Months up  12.04 %
1 YTD up  76.82 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/19/2014 10:25 AM Buy
53.30 116.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy